GSK3B and nonpapillary renal cell carcinoma: And deactivation of EGFR, AKT or GSK3β with its corresponding inhibitor could block shATF3 induced β−catenin expression, cell proliferation and cell invasion in ccRCC cells, suggesting they formed as one central signaling axis to promote ccRCC development.